Increase hepatic mitochondrial energy expenditure; reduce hypertriglyceridemia and hepatic steatosis; reduce hepatic DAGs-PKCε activity and hepatic acetyl-CoA content to reverse hepatic insulin resistance. The gene discussed is INS; the disease is fatty liver disease.